Earnings summaries and quarterly performance for Adtalem Global Education.
Executive leadership at Adtalem Global Education.
Stephen W. Beard
Chief Executive Officer
Douglas G. Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
Michael Betz
President, Walden University and Chief Digital Officer
Robert J. Phelan
Senior Vice President, Chief Financial Officer
Scott Liles
President, Medical and Veterinary
Board of directors at Adtalem Global Education.
Betty Vandenbosch
Director
Donna J. Hrinak
Director
Georgette Kiser
Director
Kenneth J. Phelan
Director
Liam Krehbiel
Director
Lisa W. Wardell
Director
Michael W. Malafronte
Lead Independent Director
Sharon L. O'Keefe
Director
William W. Burke
Director
Research analysts who have asked questions during Adtalem Global Education earnings calls.
Jeffrey Silber
BMO Capital Markets
5 questions for ATGE
Jack Slevin
Jefferies Financial Group Inc.
4 questions for ATGE
Steven Pawlak
Baird
4 questions for ATGE
Alexander Paris
Barrington Research Associates, Inc.
3 questions for ATGE
Recent press releases and 8-K filings for ATGE.
- Adtalem Global Education affirmed its FY2026 revenue guidance of $1.9 billion to $1.94 billion and raised its adjusted FY2026 EPS guidance to roughly $7.80–$8.00 from a prior range of $7.60–$7.90. This updated EPS guidance implies roughly 17%–20% year-over-year growth.
- The company reported Q2 revenue of $503.385 million, surpassing expectations, and achieved its tenth consecutive quarter of enrollment growth with a 6.3% increase to about 97,000 students.
- Adtalem returned $165 million to shareholders and showcased a strong financial profile, including a 19.6% operating margin, a 13.8% net margin, and a 17.67% return on equity (ROE).
- Adtalem Global Education reported strong Q2 FY 2026 results, with revenue increasing 12% to $503 million and adjusted earnings per share rising 34% to $2.43.
- The company raised its full-year adjusted EPS guidance for FY 2026 to a range of $7.80-$8.00, representing 17%-20% growth, while maintaining its revenue guidance of $1.9 billion-$1.94 billion.
- Total enrollment grew 6% to 97,000 students, marking the 10th consecutive quarter of enrollment growth, with Walden achieving record total enrollment of 52,400 students.
- $165 million was deployed to share repurchases in Q2, with approximately $728 million remaining on the current authorization as of December 31st.
- Adtalem Global Education reported Q2 FY26 revenue of $503.4 million, an increase of 12.4% year-over-year, with adjusted EPS of $2.43, up 34.3% year-over-year, and an adjusted EBITDA margin of 30.8%, a 290 basis point improvement.
- Total enrollment grew 6.3% year-over-year in Q2 FY26, marking the tenth straight quarter of total enrollment growth, primarily driven by the Walden and Medical & Veterinary segments.
- The company raised its FY26 adjusted EPS guidance range to $7.80 – $8.00, representing 17% to 20% year-over-year growth.
- Adtalem completed a $150 million share repurchase authorization and announced a new $750 million program, returning $165 million to shareholders through repurchases in Q2, and repaid $50 million of outstanding Term Loan B.
- Adtalem Global Education reported strong Q2 FY2026 results, with revenue growing 12% to $503 million and adjusted earnings per share increasing 34% to $2.43 compared to the prior year.
- The company raised its full-year adjusted EPS guidance to a range of $7.80-$8.00, representing 17%-20% growth. Full-year revenue guidance was maintained at 6%-8.5% growth.
- Total enrollment grew over 6% to 97,000 students, marking the 10th consecutive quarter of enrollment growth. Walden achieved record total enrollment of 52,400 students, up 13%.
- Adtalem deployed $165 million to share repurchases in Q2, with approximately $728 million remaining on its current authorization as of December 31st.
- While Chamberlain's total enrollment declined 1% in Q2, application volumes for both pre-licensure and post-licensure nursing programs are up double digits, which is expected to translate into future enrollment growth.
- Adtalem Global Education reported Q2 2026 revenue of $503.4 million, an increase of 12.4% year-over-year, and adjusted earnings per share of $2.43, up 34.3% compared to the prior year.
- The company achieved its 10th consecutive quarter of enrollment growth, with total enrollment increasing over 6% to 97,000 students. Walden recorded record total enrollments of 52,400 students, up 13%, while Chamberlain's total enrollment declined by 1%.
- Adtalem raised its full-year fiscal year 2026 adjusted EPS guidance from the previous range of $7.60-$7.90 to a new range of $7.80-$8.00, representing 17%-20% growth. Full-year revenue guidance was maintained at $1.9 billion - $1.94 billion, or 6%-8.5% growth year-over-year.
- During Q2 2026, the company deployed $165 million to share repurchases, with approximately $728 million remaining on its current authorization as of December 31st.
- Adtalem Global Education reported Q2 Fiscal Year 2026 revenue of $503.4 million, an increase of 12.4% year-over-year, with adjusted diluted earnings per share of $2.43, up 34.3% year-over-year.
- Total student enrollment grew 6.3% year-over-year to 97,010, marking the tenth consecutive quarter of growth.
- The company raised its Fiscal Year 2026 adjusted earnings per share guidance to a range of $7.80 to $8.00, while maintaining revenue guidance between $1,900 million and $1,940 million.
- Adtalem completed a $150 million share repurchase program and authorized a new $750 million program through December 2028, having repurchased $165 million of shares in the second quarter. Net leverage stood at 0.9x as of December 31, 2025.
- Adtalem Global Education reported strong second quarter fiscal year 2026 results (ended Dec. 31, 2025), with revenue up 12.4% year-over-year to $503.4 million and adjusted diluted earnings per share growing 34.3% year-over-year to $2.43.
- The company achieved its tenth consecutive quarter of total enrollment growth, reaching 97,010 students, up 6.3% year-over-year, with Walden University recording its highest total enrollment in university history.
- Adtalem raised its Fiscal Year 2026 adjusted earnings per share guidance to a range of $7.80 to $8.00.
- The company completed its $150 million share repurchase program and authorized a new $750 million share repurchase program through December 2028, having repurchased $165 million of shares in the second quarter.
- Adtalem Global Education has completed its $150 million share repurchase program, under which it repurchased approximately 1.6 million shares.
- The Board of Directors has authorized a new $750 million share repurchase program, effective through December 2028.
- Since February 2022, Adtalem has returned $913 million to shareholders by repurchasing 17.2 million shares at an average price of $52.95, resulting in a 30% reduction in shares outstanding.
- The company reported 34.9 million shares of common stock outstanding as of December 10, 2025.
- Adtalem has reduced its debt by $1.1 billion since August 31, 2021, to $508.4 million as of October 31, 2025.
- Adtalem Global Education announced plans to accelerate its existing $150 million board-authorized share repurchase program, with $136 million remaining.
- The company reaffirmed its Fiscal Year 2026 guidance, anticipating revenue between $1,900 million and $1,940 million and adjusted earnings per share between $7.60 and $7.90.
- This decision reflects confidence in the company's financial strength, evidenced by 8% year-over-year enrollment growth and 10.8% year-over-year revenue growth for the first quarter.
- Adtalem Global Education reported Q1 FY26 revenue of $462.3 million, an increase of 10.8% year-over-year, and adjusted EPS of $1.75, up 35.7% year-over-year. Adjusted EBITDA margin for the quarter was 24.2%, a 100 basis point improvement from the prior year.
- Total enrollment grew by 8.0% year-over-year to 97,359 students in Q1 FY26, marking the ninth consecutive quarter of total enrollment growth.
- The company maintained a strong financial position with $265 million in cash and equivalents as of September 30, 2025, and generated $319 million in trailing twelve months free cash flow. Adtalem also repaid $50 million of its Term Loan B balance and repurchased $8 million of shares in Q1 FY26.
- For FY 2026, Adtalem provided guidance projecting revenue between $1,900 million and $1,940 million, representing approximately 6.0% to 8.5% year-over-year growth, and adjusted EPS between $7.60 and $7.90, an approximate 14.0% to 18.5% year-over-year growth.
Quarterly earnings call transcripts for Adtalem Global Education.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
